Public Health Initiative on Alcohol Flushing

A Public Health Education and Awareness Initiative on Alcohol Flushing and Alcohol-related Cancer in Asian Communities

NCT06397716•Stanford University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Alcohol Toxicity

Interventions

ALDH2 Genotyping

Locations

United States

Locations (1)

Stanford University

Palo Alto, California, United States

Key Dates

Start Date

April 25, 2024

Primary Completion Date

December 31, 2025

Completion Date

December 31, 2025

Last Updated

December 16, 2024

Sponsors

Lead Sponsor

Stanford University

Collaborators

Stanford Center for Asian Health Research and Education

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 16, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions